Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA PFIZER JUBILANT PHARMOVA /
PFIZER
 
P/E (TTM) x -2,637.5 38.2 - View Chart
P/BV x 1.7 6.0 28.0% View Chart
Dividend Yield % 0.9 1.7 52.9%  

Financials

 JUBILANT PHARMOVA    PFIZER
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
PFIZER
Mar-23
JUBILANT PHARMOVA /
PFIZER
5-Yr Chart
Click to enlarge
High Rs4964,662 10.6%   
Low Rs2693,407 7.9%   
Sales per share (Unadj.) Rs394.4530.0 74.4%  
Earnings per share (Unadj.) Rs-4.1136.4 -3.0%  
Cash flow per share (Unadj.) Rs30.7159.4 19.3%  
Dividends per share (Unadj.) Rs5.0070.00 7.1%  
Avg Dividend yield %1.31.7 75.4%  
Book value per share (Unadj.) Rs338.6701.0 48.3%  
Shares outstanding (eoy) m159.2845.75 348.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.07.6 12.7%   
Avg P/E ratio x-93.829.6 -317.2%  
P/CF ratio (eoy) x12.425.3 49.2%  
Price / Book Value ratio x1.15.8 19.6%  
Dividend payout %-122.751.3 -239.2%   
Avg Mkt Cap Rs m60,873184,576 33.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21,6603,317 653.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,81724,248 259.1%  
Other income Rs m3831,011 37.9%   
Total revenues Rs m63,20125,258 250.2%   
Gross profit Rs m7,3178,420 86.9%  
Depreciation Rs m5,5401,055 525.1%   
Interest Rs m1,882135 1,396.1%   
Profit before tax Rs m2788,240 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9272,001 46.3%   
Profit after tax Rs m-6496,239 -10.4%  
Gross profit margin %11.634.7 33.5%  
Effective tax rate %333.524.3 1,373.7%   
Net profit margin %-1.025.7 -4.0%  
BALANCE SHEET DATA
Current assets Rs m37,62424,933 150.9%   
Current liabilities Rs m17,7246,574 269.6%   
Net working cap to sales %31.775.7 41.8%  
Current ratio x2.13.8 56.0%  
Inventory Days Days2593 26.2%  
Debtors Days Days562 2,445.4%  
Net fixed assets Rs m71,66813,780 520.1%   
Share capital Rs m159458 34.8%   
"Free" reserves Rs m53,77231,616 170.1%   
Net worth Rs m53,93132,073 168.2%   
Long term debt Rs m31,1040-   
Total assets Rs m109,29239,031 280.0%  
Interest coverage x1.162.1 1.8%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.60.6 92.5%   
Return on assets %1.116.3 6.9%  
Return on equity %-1.219.5 -6.2%  
Return on capital %2.526.1 9.7%  
Exports to sales %02.8 0.0%   
Imports to sales %4.10 11,782.5%   
Exports (fob) Rs mNA688 0.0%   
Imports (cif) Rs m2,5648 30,524.4%   
Fx inflow Rs m7,100688 1,032.2%   
Fx outflow Rs m2,5648 30,524.4%   
Net fx Rs m4,536679 667.6%   
CASH FLOW
From Operations Rs m6,6073,557 185.7%  
From Investments Rs m-5,444-361 1,510.2%  
From Financial Activity Rs m-1,567-3,458 45.3%  
Net Cashflow Rs m301-262 -115.1%  

Share Holding

Indian Promoters % 47.4 0.0 -  
Foreign collaborators % 3.3 63.9 5.1%  
Indian inst/Mut Fund % 23.2 18.2 127.5%  
FIIs % 20.3 3.0 669.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 36.1 136.7%  
Shareholders   86,588 112,456 77.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Jubilant Pharmova vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Pfizer Share Price Performance

Period Jubilant Pharmova Pfizer S&P BSE HEALTHCARE
1-Day -0.93% -4.83% 1.18%
1-Month 1.81% -8.27% -0.75%
1-Year 108.47% 21.74% 61.82%
3-Year CAGR -6.91% -2.08% 18.16%
5-Year CAGR -2.86% 4.94% 19.79%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.